Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cancer|July 10, 2019
Soft-tissue sarcoma in adolescents and young adults compared with older adults: A report among 5000 patients from the Scandinavian Sarcoma Group Central RegisterKarin E Papworth, Vidal M Arroyo, Emelie Styring, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 6, 2023
Osteosarcomas With Few Chromosomal Alterations or Adult Onset Are Genetically HeterogeneousValeria Difilippo, Karim H Saba, Emelie Styring, et al.
Annals of Surgical Oncology|April 3, 2012
Radiation-associated angiosarcoma after breast cancer: high recurrence rate and poor survival despite surgical treatment with R0 resectionJojanneke M Seinen, Emelie Styring, Vincent Verstappen, et al.
Breast Cancer Research and Treatment|January 21, 2010
Changing clinical presentation of angiosarcomas after breast cancer: from late tumors in edematous arms to earlier tumors on the thoracic wallEmelie Styring, Josefin Fernebro, Per-Ebbe Jönsson, et al.
Journal of Surgical Oncology|October 21, 2015
Referral patterns, treatment and outcome of high-grade malignant bone sarcoma in Scandinavia--SSG Central Register 25 years' experienceOlga Zaikova, Kirsten Sundby Hall, Emelie Styring, et al.
Materials Today. Bio|March 10, 2022
Bone mineral: A trojan horse for bone cancers. Efficient mitochondria targeted delivery and tumor eradication with nano hydroxyapatite containing doxorubicinYang Liu, Aftab Nadeem, Sujeesh Sebastian, et al.
NPJ Genomic Medicine|September 25, 2024
CDK4 is co-amplified with either TP53 promoter gene fusions or MDM2 through distinct mechanisms in osteosarcomaKarim H Saba, Valeria Difilippo, Emelie Styring, et al.
The Journal of Pathology|November 27, 2023
Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathwayKarim H Saba, Valeria Difilippo, Michal Kovac, et al.
The Journal of Pathology. Clinical Research|June 17, 2020
Loss of NF2 defines a genetic subgroup of non-FOS-rearranged osteoblastomaKarim H Saba, Louise Cornmark, Jakob Hofvander, et al.
Acta Orthopaedica|March 8, 2017
The Scandinavian Sarcoma Group Central Register: 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcomaClement Trovik, Henrik C F Bauer, Emelie Styring, et al.
Pageof 2